Large-scale testing (Phase 3)Active Not RecruitingNCT03477500
What this trial is testing
Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)
Who this might be right for
Multiple Sclerosis
Haukeland University Hospital 100